A Swiss company focusing on the performance and growth of promising technologies in the life sciences sector
Xlife Sciences AG
Who we are
Xlife Sciences AG is a listed (m:access: XLS) Swiss company focusing on the performance and growth of promising technologies and therapies in the life sciences sector. With a track record of more than 28 years, we bridge the gap between research and development and healthcare markets.
Xlife Sciences AG focuses on the early stage of the life sciences industry. A company in the biotech sector goes through the following phases: invention disclosure, preclinical phase (followed by phase 1, phase 2 and phase 3) and finally, the approval. Xlife Sciences AG invests intelligently in the first two phases: invention disclosure and the preclinical phase, and thus has a comparatively above average success rate for the biotech sector.